Redeye believes the Q2 report from Lagercrantz was strong, especially from a profit perspective, and that the signals from management indicate a continued positive development despite the uncertain macro environment. While organic growth decelerated it is balanced by a continued strong growth from acquisitions. We think the share is trading at compelling levels.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Lagercrantz - Scaling up its acquisition pace

© Modular Finance, source Nordic Press Releases